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Abstract The synthesis and characterization of four new nitroxide-radical 
containing next generation maleimides are presented. Each new label has a 
single leaving group which is either a phenoxyl or bromide. The linker 
between the maleimide and the nitroxide-containing framework is either a 
racemic mixture of a short chain or an achiral longer chain. These molecules 
have been designed to site-specifically label vicinal cysteines in proteins for 
magnetic resonance studies. The characterization of the final products 
includes crystallography and the labeling of Sperm Whale Myoglobin protein.	
Key words Next generation maleimide, succinimide, nitroxide spin label, 
radical, EPR spectroscopy, PRE NMR, cysteine labeling, site directed spin 
labeling. 	Spin	labels	are	small	molecules	that	attach	to	larger	molecules	of	interest	and	that	stabilize	a	free	radical.	The	spin	labels	are	most	likely	 to	 be	 used	 to	 report	 on	 their	 microenvironment,	accessibility,	 motional	 dynamics	 or	 to	 enable	 nanometre-scale	distance	 measurements	 by	 electron	 paramagnetic	 resonance	(EPR)	 spectroscopy.3	 Alternatively,	 they	 may	 be	 used	 as	paramagnetic	 relaxation	 enhancing	 reagents	 in	 nuclear	magnetic	 resonance	 (NMR)	 spectroscopy.4	 It	 is	 therefore	 often	desirable	 to	 have	 a	 spin	 label	 that	 demonstrates	 little	conformational	freedom	while	having	enough	flexibility	to	avoid	disruption	of	the	protein	fold.	Commonly	these	labels	stabilize	a	nitroxyl	radical	as	part	of	a	5	or	 6	 membered	 carbon	 framework	 and	 are	 hence	 called	nitroxide	spin	labels.	These	are	functionalized	to	react	at	the	site	of	 interest.	 For	 proteins	 this	 site	 is	 often	 the	 thiol	 of	 cysteine.	The	 labels	 can	 be	 made	 to	 covalently	 attach	 reversibly	 or	irreversibly	with	short	or	long	linkers.	Attachment	chemistries		
 
Scheme 1 Proposed method for labeling proteins containing multiple free 
cysteines but with only one vicinal pair using a next generation maleimide. 
The maleimide and succinimide linkages are shown. In this work R is the 
nitroxide-containing framework (pyrrolinoxyl or pyrrolidinoxyl) and X a Br or 
OPh leaving group. The NGM labels made are shown as 1, 2, 3 and 4. 
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Scheme 2 Reagents and conditions: (a) Ethyl chloroformate, Et3N, toluene, 
quantitative; (b) NaBH4, EtOH, 83%; (c) TsCl, Et3N, DCM, 67%; (d) NH3, MeOH, 
80%; (e) Bromomaleic anhydride (1 equiv.), AcOH, 47%; (f) phenol (15 equiv), 
t-BuOK (1.2 equiv.), dioxane, 92%. utilize	 iodocetamides	 and	 maleimides	 to	 give	 carbon-sulfur	bonds,	 and	 thiosulfonates	 which	 result	 in	 disulfide	 linked	reagents.5	Proteins	 which	 are	 excreted	 from	 the	 biological	 cell	 rarely	contain	 cysteines	 suitable	 for	 labeling.	Therefore	 cysteines	 can	be	engineered	into	sites	of	interest	in	proteins	and	labeled	using	site	 directed	 spin	 labeling	 (SDSL).3	 However	 many	 excreted	proteins	contain	disulfide	bonds,	where	two	cysteines	are	close	in	 space	 rather	 than	 necessarily	 sequence,	 and	 intracellular	proteins	 contain	 cysteines	 much	 more	 frequently.6	 These	situations	 are	 not	 ideal	 for	 designing	 SDSL	 experiments.	 One	method	 to	 overcome	 this	 problem	 is	 to	 incorporate	 unnatural	amino	 acids	 into	 the	 protein	 sequence.	 These	 have	bioorthogonal	 reactivities	 and	 can	 therefore	 undergo	 selective	labeling,	alternatively	there	is	a	published	example	of	a	nitroxyl	radical	 being	 incorporated	 directly.3,7	This	 field	 is	 progressing	but	at	 the	moment	 the	 technology	cannot	be	readily	applied	to	any	 protein,	 and	 the	 spin	 labels	 are	 on	 long	 flexible	 linkers	which	is	a	disadvantage	for	many	applications.	
 
Scheme 3 Reagents and conditions: (a) Bromomaleic anhydride (1 equiv.), 
ether, 87%; (b) NaOAc (1 equiv.), Ac2O, 64%; (c) phenol (15 equiv), t-BuOK 
(1.2 equiv.), dioxane, 92%. Here	 we	 report	 on	 the	 synthesis	 of	 spin	 labels	 based	 on	 next	generation	maleimides.8	Following	 literature	precedence,	 these	should	 bind	 to	 pairs	 of	 cysteines	 which	 are	 close	 in	 space	(“vicinal”)	via	a	succinimide	bridge	but	bind	to	single	cysteines	with	 a	 sulfur-maleimide	 bond	 which	 can	 be	 reversed,	 see	
Scheme	1.	The	labels	proposed	here	are	different	to	the	existing	next	 generation	 maleimide	 spin	 labels,	 TPMP	 and	 TPMCP	proposed	 by	 Baker	 and	 co-workers	 as	 spinostic	 reagents.9	 In	that	work	they	did	not	use	succinimide	bridging	but	instead	had	two	 leaving	 groups	 to	 result	 in	 a	 maleimide	 bridged	 product.	Here	 we	 wish	 to	 create	 spin	 labels	 that	 will	 give	 a	 different	chemical	 reactivity,	 depending	 on	 whether	 single	 or	 pairs	 of	cysteines	are	bound,	to	enable	selective	labeling	of	only	pairs	of	cysteines	(Scheme	1).		
 
Figure 1 Ball and stick representation of compounds 1 – 4 from X-ray 
crystallography. The hydrogen atoms are omitted for clarity except for the 
stereocentre at C3’ for 3 and 4. For 3 this representation is from one of 
three crystallographically independent molecules. Next	 generation	maleimides	have	 a	 leaving	 group	 and	 this	 can	be	altered	to	tune	for	desired	properties.	It	has	previously	been	shown	that	bromide	may	leave	so	rapidly	that	adjacent	pairs	of	cysteines	 will	 each	 bind	 a	 maleimide	 marker	 whereas	 an	 O-phenyl	leaves	less	efficiently,	thus	favouring	the	intramolecular	reaction	and	 formation	of	a	succinimide	bridged	product.10	We	have	therefore	made	each	label	type	with	Br	(1		and	3)	and	OPh	(2	 and	 4)	 leaving	 groups	 on	 the	 maleimide.	 The	 two	 families	consist	 of	 either	 a	 pyrrolinoxyl	 (1	 and	2)	 or	 pyrrolidinoxyl	 (3	and	 4)	 carbon	 framework	 stabilizing	 the	 radical.	 The	
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pyrrolidinoxyl	has	an	extra	stereocentre	but	one	less	carbon	in	the	 linker	 between	 the	 nitroxide	 ring	 and	 the	 nitrogen	 of	 the	maleimide.	 An	 advantage	 of	 the	 pyrrolinoxyl	 ring	 is	 that	 it	 is	expected	 to	have	greater	 stabilizing	properties	 for	 the	nitroxyl	radical.	
 
Figure 2 LC-MS spectra showing intact mass of the sperm whale myoglobin 
S3C (initiator Met present and counted as residue 0). Protein samples were 
analysed on a Waters 2795 HPLC and LCT, which had been calibrated with 
horse heart myoglobin, desalting with a Waters MassPrep on-line desalting 
cartridge, eluting with an increasing gradient of acetonitrile. The envelope of 
multiply charged signals was deconvoluted using MaxEnt1 software to give 
the molecular mass of the protein: A) Unlabeled, expected mass 18371.2, 
found 18372; B) with 2, following loss of Br- expected mass 18620.5, found 
18619; C) with 3, following loss of -OPh expected mass 18606.5, found 
18608.  Carboxylic	acid11	5	(Scheme	2)	was	converted	into	alcohol	7	via	the	 intermediate	mixed	 anhydride	6.	 This	 route	 was	 favoured	over	lithium	aluminium	hydride	reduction	which	can	lead	to	low	yield	and	a	lack	of	reproducibility.12	The	two-step	procedure	has	previously	been	used	by	Kirilyuk	et	al.	 for	 the	synthesis	of	2,5-bis(spirocyclohexane)-substitued	 nitroxides	 and	 in	 our	 hands	gave	 7,	 reproducibly,	 at	 83%	 yield.13	 Alcohol	 7	 was	 then	converted	 to	 tosylate	 8,	 and	 the	 tosyl	 group	 was	 substituted	with	 ammonia,	 yielding	 amine	 9.14	 Efficient	 amination	 (80%)	was	 achieved	 using	 a	 7	 N	 solution	 of	 ammonia	 in	 methanol.	Amine	 9	 was	 transformed	 using	 a	 one-step	 procedure	 into	bromomaleimide	 1	 in	 the	 presence	 of	 bromomaleimic	anhydride	using	acetic	acid	as	the	solvent.15	This	reaction	gave	1	with	 47%	 yield	 and	 the	 nitroxyl	 group	 was	 shown	 to	 be	unaffected	 by	 the	 reaction	 conditions,	 i.e.	 no	 reduction	 was	observed	by	continuous	wave	(CW)	EPR	spectroscopy.	When	 this	 one-step	 bromomaleimide	 formation	 reaction	 was	attempted	 on	 the	 commercial	 aminopyrrolidinoxyl	 radical	 10	the	formation	of	a	complex	mixture	was	observed.	This	mixture	
did	not	give	any	signal	in	CW	EPR	spectroscopy,	suggesting	that	reduction	 of	 the	 nitroxyl	 moiety	 had	 occurred.	 Thus,	 3	 was	synthesized	from	amine	10,	using	a	two-step	reaction	pathway	(Scheme	 3).16	 This	 procedure	 consists	 of	 the	 synthesis	 of	 a	mixture	 of	 compounds	 11	 and	 11’,	 using	 bromomaleic	anhydride,	 followed	 by	 an	 intramolecular	 cyclisation	 giving	compound	3	with	an	overall	yield	of	56%.	In	both	families	of	NGM	labels,	the	OPh	derivative	(2	and	4)	was	synthesized,	with	an	excellent	yield,	 from	the	bromo	precursor	(6	 and	 10	 respectively)	 using	 phenol	 in	 the	 presence	 of	 t-BuOK.10	
 
Figure 3 X-band CW EPR spectra at room temperature (Bruker EMX with 
SHQ resonator) for the labels 2 (longer linker, black) and 4 (shorter linker, 
red) after addition to Sperm Whale Myoglobin S3C and measured in PBS 
buffer with 50% glycerol. Data have been overlaid at the central y = 0 point to 
correct for small differences in microwave frequency and have been 
normalised by their maximum intensity. Spectra were taken under non-
saturating conditions at room temperature with a modulation amplitude of 
0.8 G per point. Continuous	wave	(CW)	EPR	spectroscopy	of	the	compounds	did	not	demonstrate	any	decrease	in	radical	content	over	the	course	of	the	reactions.	The	structure	of	the	compounds	was	confirmed	through	 NMR	 spectroscopy,	 mass	 spectrometry	 and	 X-ray	crystallography.	 The	 crystallographic	 structures	 are	 presented	in	Figure	1.	The	crystals	were	racemic	and	diffracted	well	to	give	single	independent	results	for	1,	2	and	4.	Crystals	of	3	gave	less	clear	results.	However,	HPLC,	TLC	and	NMR	results	for	3	did	not	indicate	that	it	was	less	pure	than	the	other	end	products.	To	demonstrate	that	the	labels	bind	to	proteins	through	loss	of	either	their	bromo	or	O-Phenyl	groups,	and	to	see	if	there	were	any	 clear	 differences	 in	 mobility	 between	 the	 families,	 1	 -	 4	were	 added	 to	 Sperm	Whale	Myoglobin.	 This	was	 an	 available	protein	containing	one	cysteine	residue	 for	 labeling	at	position	3,	which	is	a	serine	in	the	wild	type.17	A	10	times	excess	of	spin	label	 was	 incubated	 with	 the	 protein	 for	 1	 hour	 at	 room	temperature	or	at	4°C	overnight.	Size	exclusion	chromatography	was	then	employed	to	remove	unreacted	label.	LC-MS	confirmed	that	 all	 four	 labels	 bound	 to	myoglobin	 and	 gave	 the	 expected	mass	increase,	with	no	free	protein	observed	(Figure	2).	The	CW	EPR	 spectra	 for	 these	 samples	 show	 that	 the	 labels	 have	 a	reduced	 mobility	 compared	 to	 the	 free	 labels	 which	 gave	 a	characteristic	 sharp	 three-line	 spectrum.	 The	 broader	 spectra	
A 
B 
C 
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for	the	shorter	linked	spin	labels,	3	and	4,	demonstrate	that	they	have	 a	 further	 reduced	 conformational	 freedom	 compared	 to	the	longer	linkers	of	1	and	2,	see	figure	3.9,18		In	 conclusion,	 four	 new	 nitroxide-containing	 spin	 labels	 have	been	 synthesized	 with	 next	 generation	 maleimide	functionalities.	 This	may	 lead	 to	 the	 ability	 to	 selectively	 bind	the	spin	label	to	vicinal	cysteines	and	trials	are	ongoing.	
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pyrrol-1-yloxy	(9)	A	solution	of	8	(1.5	g;	4.6	mmol)	in	anhydrous	methanol	was	added	dropwise	into	ammonia	solution	(75.0	mL;	7	N	 in	 MeOH).	 The	mixture	 was	 stirred	 for	 2	 h	 at	 rt,	 then	 left	 to	stand	 overnight.	 The	 solvent	 was	 evaporated	 under	 reduced	pressure.	 The	 residue	 was	 treated	 with	 a	 buffer	 solution	 (60.0	mL;	 mixture	 of	 citric	 acid	 and	 Na2HPO4)	 at	 pH	 5	 and	 extracted	with	 ether.	 The	 aqueous	 layer	 was	 saturated	 with	 sodium	hydroxide	 and	 extracted	 with	 ether.	 The	 extract	 was	 dried	 and	concentrated	 yielding	 9	 (706.0	 mg;	 90	 %)	 as	 an	 orange	 oil.	 1H	NMR	(400	MHz,	CDCl3	+	phenylhydrazine	to	reduce	the	nitroxide	radical	 to	a	diamagnetic	N-hydroxylamine,22	since	we	found	that	our	product	was	degraded	by	Na2S2O4)	δ	1.24	(s,	6H),	1.25	(s,	6H),	
Synlett  Letter /  Cluster /  New Tools  
Template	for	SYNTHESIS	©	Thieme		Stuttgart	·	New	York	 2016-06-06	 page	5	of	5	
3.31	 (d,	 J	 =	 1.8	Hz,	 2H),	 5.42	 (s,	 1H);	 HRMS	 ESI	 (m/z)	 calcd	 for	C9H18ON2+,	170.1414 found	170.1408.	
3-((3-bromo-2,5-dihydro-1H-pyrrole-2,5-dione-1-yl)methyl)-
2,5-dihydro-2,2,5,5-tetramethyl-1H-pyrrol-1-yloxy	(1)	Bromomaleic	 anhydride	 (388.2	 µL;	 4.2	 mmol)	 was	 dissolved	 in	acetic	 acid	 (7.0	 mL).	 Nitroxyl	9	 (707.9	 mg;	 4.2	 mmol)	 in	 acetic	acid	(7.0	mL)	was	added,	and	the	reaction	was	heated	at	80°C	for	3	h.	The	solvent	was	removed	under	vacuo	and	the	mixture	was	purified	by	column	chromatography	(cyclohexane/EtOAc)	to	give	the	 bromomaleimides	1	 (644.7	mg;	 47%)	 as	 an	 orange	powder.	1H	NMR	(400	MHz,	CDCl3	+	phenylhydrazine)	δ	1.38	(s,	6H),	1.45	(s,	6H),	4.17	(d,	J	=	1.4	Hz;	2H),	5.40	(s,	1H)	 ,	6.94	(s,	1H);	HRMS	NSI	(m/z)	calcd	for	C13H17O3N2Br+,	328.0417 found	328.0417;	mp	=	146-147°C.	
3-(3-Bromo-2,5-dihydro-1H-pyrrole-2,5-dione-1-yl)-2,5-
dihydro-2,2,5,5-tetramethyl-1H-pyrrol-1-yloxy	(3)	To	 a	 stirred	 solution	 of	 amine	10	 (489.0	mg;	 3.1	mmol)	 in	 dry	ether	 (24.7	 mL)	 bromomaleic	 anhydride	 (286.7	 µL;	 3.1	 mmol)	was	 added.	 The	 reaction	 was	 left	 stirring	 at	 rt	 for	 3	 h.	 The	precipitate	was	filtered	and	washed	with	ether	yielding	a	mixture	of	11	and	11′	(910.0	mg;	87%)	as	a	yellow	solid.	The	 mixture	 of	 11	 and	 11′	 (910	 mg;	 2.7	 mmol)	 and	 sodium	acetate	(222.2	mg;	2.7	mmol)	were	dissolved	in	acetic	anhydride	(13.5	mL)	 and	 heated	 at	 60-70°C	 for	 3	 h.	 The	 reaction	mixture	was	then	concentrated,	dissolved	in	DCM	and	filtered.	The	filtrate	was	 concentrated	 and	 purified	 by	 column	 chromatography	(cyclohexane/EtOAc)	to	give	3	(853	mg;	64%)	as	an	orange	solid.	1H	NMR	(400	MHz,	CDCl3	+	phenylhydrazine)	δ	1.08	(s,	3H),	1.25	(s,	3H),	1.26	 (s,	3H),	1.36	 (s,	3H)	1.82	 (dd,	 J	=	12.5,	8.8	Hz;	1H),	2.93	(dd,	J	=	12.5,	11.0	Hz,	1H),	4.47	(dd,	J	=	11.0,	8.8	Hz,	1H),	6.89	(s,	 1H);	 HRMS	 ESI	 (m/z)	 calcd	 for	 C12H16O3N2BrNa+,	 338.0237 found	338.0223;	mp	=	101-102°C.	
Phenoxymaleimide	2	and	4;	General	procedure	To	 molten	 phenol	 (13.2	 mmol),	 potassium	 tert-butoxide	 (1.1	mmol)	 in	 dry	 dioxane	 (0.8	 mL)	 was	 added	 dropwise	 and	 the	solution	was	 left	 stirring	 for	10	min	at	40	 °C.	Then	a	solution	of	bromomaleimide	1	or	3	(0.8	mmol)	in	dry	dioxane	(0.8	mL)	was	added	dropwise	and	the	resulting	mixture	was	stirred	at	40	°C	for	30	 minutes.	 After	 this	 time,	 the	 solvent	 was	 evaporated	 under	reduced	 pressure.	 The	 mixture	 was	 purified	 by	 column	chromatography	(cyclohexane/EtOAc)	 to	give	 the	corresponding	phenoxymaleimide.	
3-((3-phenoxy-2,5-dihydro-1H-pyrrole-2,5-dione-1-
yl)methyl)-2,5-dihydro-2,2,5,5-tetramethyl-1H-pyrrol-1-
yloxy	 (2)	yield:	279	mg	 (92%);	Aspect:	 light	yellow	powder;	 1H	NMR	(400MHz,	CDCl3	+	phenylhydrazine)	δ	1.32	(s,	6H),	1.40	(s,	6H),	4.14	(d,	J	=	1.4	Hz;	2H),	5.34	(s,	1H)	,	5.48	(s,	1H),	7.36-7.29	(m,	 2H),	 7.51-7.43	 (m,	 3H);	 HRMS	 NSI	 (m/z)	 calcd	 for	C19H22O4N2+,	342.1574 found	342.1570;	mp	=	92-94°C.	
3-(3-Phenoxy-2,5-dihydro-1H-pyrrole-2,5-dione-1-yl)-2,5-
dihydro-2,2,5,5-tetramethyl-1H-pyrrol-1-yloxy	 (4)	 yield:	 345	mg	 (92%),	 Aspect:	 yellow	 solid,	 1H	 NMR	 (400MHz,	 CDCl3	 +	
phenylhydrazine)	δ	1.13	(s,	3H),	1.24	(s,	3H),	1.27	(s,	3H),	1.36	(s,	3H),	1.80	(dd,	J	=	12.4,	8.7	Hz,	1H),	2.98	(dd,	J	=	11.2,	12.4	Hz,	1H),	4.46	 (dd,	 J	 =	 11.2,	 8.7	 Hz,	 1H),	 5.29	 (s,	 1H),	 7.37-7.30	 (m,	 2H),	7.54-7.43	 (m,	 3H);	 HRMS	 ESI	 (m/z)	 calcd	 for	 C18H21N2O4Na+,	352.1394	found	352.1371;	mp	=	120-122°C.																													.	 		
	
 
